Journey Medical (DERM)
(Delayed Data from NSDQ)
$4.83 USD
+0.32 (7.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.87 +0.04 (0.83%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth B Momentum F VGM
Earnings News For DERM
-
Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates
-
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
-
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
-
Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?
-
Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
-
Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates
-
Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
-
Journey Medical Corporation (DERM) Reports Q1 Loss, Lags Revenue Estimates
-
Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
-
Journey Medical Corporation (DERM) Reports Q4 Loss, Misses Revenue Estimates
-
Journey Medical Corporation (DERM) Reports Q3 Loss, Misses Revenue Estimates
-
Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
-
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates
-
Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
-
Dermira (DERM) Reports Q3 Loss, Tops Revenue Estimates
-
Dermira (DERM) Reports Q2 Loss, Tops Revenue Estimates
-
Earnings Preview: Dermira (DERM) Q2 Earnings Expected to Decline
-
Dermira (DERM) Reports Q1 Loss, Lags Revenue Estimates
-
Dermira (DERM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Dermira (DERM) Reports Q3 Loss, Lags Revenue Estimates
-
Dermira (DERM) Q3 Earnings Preview: What to Know Ahead of the Release
-
Dermira (DERM) Reports Q2 Loss, Tops Revenue Estimates